Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst TOIIW 深 滬
等待開盤 06-25 09:30:00 美东时间
0.0425
0.000
0.00%
華盛通- 最 高0.00
- 今 開0.0425
- 成交量 50股
- 最 低 0.00
- 昨 收 0.0425
- 總市值 0
- 52周最高 0.2725
- 市盈率 靜 --
- 換手率 Infinity.00%
- 52周最低 0.025
- 委 比 11.01%
- 總股本 --
- 歷史最高 3.86
- 量 比 0.02
- 振 幅 0.00%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oncology Institute 10% owner Jorey Chernett buys 12,000 shares for $57,000
Oncology Institute 10% owner Jorey Chernett buys 12,000 shares for $57,000 Oncology Institute 10% owner Jorey Chernett bought 12,000 common shares at USD 4.75 each. Chernett’s direct holding rose to 10,579,858 shares following the purchase. Disclaimer: This news brief was created by Public Technolog
06-05 21:38
These low-priced stocks are flashing overbought signals
Stocks trading below $10 often attract retail investors looking for high-growth opportunities at relatively low entry prices. However, many of these low-priced equities can become overheated during st...
06-02 18:23
Oncology Institute 10% owner Jorey Chernett acquires common shares worth $156,845
Oncology Institute 10% owner Jorey Chernett acquires common shares worth $156,845 The Oncology Institute disclosed open-market purchases by 10% owner Jorey Chernett. Chernett bought 38,500 shares at prices of USD 4.05 to USD 4.07. His direct holding rose to 10,567,858 shares. Disclaimer: This news b
05-21 21:36
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
The Oncology Institute, Inc. (NASDAQ: TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference on May 21, 2026, in Marina Del Rey, CA. They will engage in a fireside chat from 9:00–9:40 a.m. PT. A webcast of the presentation will be available via the Company’s Investor Relations website. Founded in 2007, TOI provides specialized, value-based cancer care to approxim...
05-13 13:00
The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement
The Oncology Institute of Hope and Innovation achieved $1.8 million in Medicare savings during Performance Period 3 of CMS's Enhancing Oncology Model, with per-episode savings exceeding $6,400. This marks a significant increase from the previous period. For the second consecutive period, the organization earned the maximum score for avoiding emergency department visits and hospital admissions. Success was driven by its High-Value Cancer Care prog...
04-13 13:00
10% owner Jorey Chernett acquires USD 83,750 of The Oncology Institute common shares
10% owner Jorey Chernett acquires USD 83,750 of The Oncology Institute common shares Jorey Chernett, a 10% owner of Oncology Institute, reported buying 25,000 common shares. The reported weighted average purchase price was USD 3.35 per share. Following the transaction, Chernett reported beneficial o
03-23 21:33
Oncology Institute Updates Investors With New Presentation
Oncology Institute ( ($TOI) ) just unveiled an update. The Oncology Institute, ...
03-14 05:50
Why Tempus AI Stock Is Up Wednesday?
Tempus AI shares are trading higher Wednesday after Needham analyst Ryan MacDonald reiterated a Buy rating and maintained a $75 price target.
03-11 22:39
Tempus AI Study Shows Advanced Genomic Profiling Uncovers New Treatment Options For Cancer Patients
Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the publication of a new study in JCO Precision Oncology highlighting how advanced features of
03-11 20:42
